Works by Wels, Winfried

Results: 69

Preclinical assessment of CARNK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1254821

By:

Shankar, Nivedha Murali;
Ortiz-Montero, Paola;
Kurzyukova, Anastasia;
Rackwitz, Wiebke;
Künze, Stephan R.;
Wels, Winfried S.;
Tonn, Torsten;
Knopf, Franziska;
Eitler, Jiri

Publication type:

Article

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1228894

By:

Heim, Catrin;
Moser, Laura M.;
Kreyenberg, Herman;
Bonig, Halvard B.;
Tonn, Torsten;
Wels, Winfried S.;
Gradhand, Elise;
Ullrich, Evelyn;
Meister, Michael T.;
Koerkamp, Marian Groot;
Holstege, Frank C. P.;
Drost, Jarno;
Klusmann, Jan-Henning;
Bader, Peter;
Merker, Michael;
Rettinger, Eva

Publication type:

Article

Optical Imaging of Cellular Immunotherapy against Prostate Cancer.

Published in:

Molecular Imaging, 2009, v. 8, n. 1, p. 15, doi. 10.2310/7290.2009.00002

By:

Tavri, Sidhartha;
Jha, Priyanka;
Meier, Reinhard;
Henning, Tobias D.;
Müller, Tina;
Hostetter, Daniel;
Knopp, Christiane;
Johansson, Magnus;
Reinhart, Verena;
Boddington, Sophie;
Sista, Akhilesh;
Wels, Winfried S.;
Daldrup-Link, Heike E.

Publication type:

Article

Liposome-based Systems for Anti-tumor Vaccination: Influence of Lipopeptide Adjuvants.

Published in:

Journal of Liposome Research, 2006, v. 16, n. 3, p. 205, doi. 10.1080/08982100600848736

By:

Heurtault, Béatrice;
Thomann, Jean-Sébastien;
Jedrzejewska, Justyna;
Wels, Winfried S.;
Schuber, Francis;
Frisch, Benoît

Publication type:

Article

Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells.

Published in:

Cells (2073-4409), 2024, v. 13, n. 3, p. 246, doi. 10.3390/cells13030246

By:

Kiefer, Anne;
Prüfer, Maren;
Röder, Jasmin;
Pfeifer Serrahima, Jordi;
Bodden, Malena;
Kühnel, Ines;
Oberoi, Pranav;
Wels, Winfried S.

Publication type:

Article

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity.

Published in:

Cells (2073-4409), 2020, v. 9, n. 4, p. 811, doi. 10.3390/cells9040811

By:

Oberoi, Pranav;
Kamenjarin, Kathrina;
Villena Ossa, Jose Francisco;
Uherek, Barbara;
Bönig, Halvard;
Wels, Winfried S.

Publication type:

Article

Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 958, doi. 10.3109/10428194.2011.634048

By:

Boissel, Laurent;
Betancur, Monica;
Lu, Weiquan;
Wels, Winfried S.;
Marino, Teresa;
Van Etten, Richard A.;
Klingemann, Hans

Publication type:

Article

Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery.

Published in:

FEBS Journal, 2005, v. 272, n. 16, p. 4221, doi. 10.1111/j.1742-4658.2005.04834.x

By:

Sloots, Arjen;
Wels, Winfried S.

Publication type:

Article

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.

Published in:

2021

By:

Hegde, Meenakshi;
Mukherjee, Malini;
Grada, Zakaria;
Pignata, Antonella;
Landi, Daniel;
Navai, Shoba A;
Wakefield, Amanda;
Fousek, Kristen;
Bielamowicz, Kevin;
Chow, Kevin Kh;
Brawley, Vita S;
Byrd, Tiara T;
Krebs, Simone;
Gottschalk, Stephen;
Wels, Winfried S;
Baker, Matthew L;
Dotti, Gianpietro;
Mamonkin, Maksim;
Brenner, Malcolm K;
Orange, Jordan S

Publication type:

journal article

Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells.

Published in:

Prostate, 2001, v. 47, n. 1, p. 21, doi. 10.1002/pros.1043

By:

Wang, Ling;
Liu, Bolin;
Schmidt, Mathias;
Lu, Yang;
Wels, Winfried;
Fan, Zhen

Publication type:

Article

PB1715: UNLEASHING NATURAL KILLER (NK) CELLS TO PROMOTE ANTI-LEUKEMIC IMMUNITY.

Published in:

2023

By:

Tsoukala, Ioanna;
Schäffer, Alexander;
Tirado-Gonzalez, Irene;
Röder, Jasmin;
Serrahima, Jordi Pfeifer;
Mosa, Mohammed H.;
Seotopo, Devona;
Descot, Arnaud;
Wels, Winfried S.;
Medyouf, Hind

Publication type:

Abstract

Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells.

Published in:

Life (2075-1729), 2021, v. 11, n. 4, p. 269, doi. 10.3390/life11040269

By:

Strobel, Sophia B.;
Machiraju, Devayani;
Hülsmeyer, Ingrid;
Becker, Jürgen C.;
Paschen, Annette;
Jäger, Dirk;
Wels, Winfried S.;
Bachmann, Michael;
Hassel, Jessica C.

Publication type:

Article

CD19- CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies.

Published in:

Journal of Cellular & Molecular Medicine, 2016, v. 20, n. 7, p. 1287, doi. 10.1111/jcmm.12810

By:

Romanski, Annette;
Uherek, Christoph;
Bug, Gesine;
Seifried, Erhard;
Klingemann, Hans;
Wels, Winfried S.;
Ottmann, Oliver G.;
Tonn, Torsten

Publication type:

Article

NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.

Published in:

Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 3, p. 569, doi. 10.1111/j.1582-4934.2011.01343.x

By:

Esser, Ruth;
Müller, Tina;
Stefes, Dörthe;
Kloess, Stephan;
Seidel, Diana;
Gillies, Stephen D.;
Aperlo-Iffland, Christel;
Huston, James S.;
Uherek, Christoph;
Schönfeld, Kurt;
Tonn, Torsten;
Huebener, Nicole;
Lode, Holger N.;
Koehl, Ulrike;
Wels, Winfried S.

Publication type:

Article

Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy.

Published in:

Transfusion Medicine & Hemotherapy, 2025, v. 52, n. 1, p. 42, doi. 10.1159/000540962

By:

Gierschek, Fenja;
Schlueter, Juliane;
Kühnel, Ines;
Feigl, Frederik Fabian;
Schmiedel, Dominik;
Prüfer, Maren;
Buchinger, Leon;
Cerwenka, Adelheid;
Cappel, Claudia;
Huenecke, Sabine;
Köhl, Ulrike;
Wels, Winfried S.;
Ullrich, Evelyn

Publication type:

Article

Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin.

Published in:

International Journal of Cancer, 1998, v. 75, n. 6, p. 878, doi. 10.1002/(SICI)1097-0215(19980316)75:6<878::AID-IJC10>3.0.CO;2-#

By:

Schmidt, Mathias;
Reiser, Pia;
Hills, David;
Gullick, William J.;
Wels, Winfried

Publication type:

Article

Targeted therapy of Schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin.

Published in:

International Journal of Cancer, 1997, v. 73, n. 1, p. 117, doi. 10.1002/(SICI)1097-0215(19970926)73:1<117::AID-IJC18>3.0.CO;2-D

By:

Altenschmidt, Uwe;
Schmidt, Mathias;
Groner, Bernd;
Wels, Winfried

Publication type:

Article

Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects.

Published in:

International Journal of Cancer, 1997, v. 70, n. 6, p. 682, doi. 10.1002/(SICI)1097-0215(19970317)70:6<682::AID-IJC10>3.0.CO;2-C

By:

Groner, Bernd;
Wick, Bettina;
Jeschke, Margit;
Fiebig, Heinz-Herbert;
Dengler, Wolfgang;
Runau, Tatiana;
Mihatsch, Michael;
Kahl, Ralf;
Schmidt, Mathias;
Wels, Winfried;
Stöcklin, Elisabeth

Publication type:

Article

Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6-specific SCFV: ζ-chimera.

Published in:

International Journal of Cancer, 1996, v. 68, n. 2, p. 232, doi. 10.1002/(SICI)1097-0215(19961009)68:2<232::AID-IJC16>3.0.CO;2-C

By:

Hekele, Armin;
Dall, Peter;
Moritz, Dirk;
Wels, Winfried;
Groner, Bernd;
Herrlich, Peter;
Ponta, Helmut

Publication type:

Article

A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor.

Published in:

International Journal of Cancer, 1996, v. 65, n. 4, p. 538, doi. 10.1002/(SICI)1097-0215(19960208)65:4<538::AID-IJC24>3.0.CO;2-4

By:

Schmidt, Mathias;
Hynes, Nancy E.;
Groner, Bernd;
Wels, Winfried

Publication type:

Article

Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.

Published in:

International Journal of Cancer, 1995, v. 60, n. 5, p. 730, doi. 10.1002/ijc.2910600527

By:

Jeschke, Margit;
Wels, Winfried;
Dengler, Wolfgang;
Imber, Roland;
Stöcklin, Elisabeth;
Groner, Bernd

Publication type:

Article

EGF receptor and p185.

Published in:

International Journal of Cancer, 1995, v. 60, n. 1, p. 137, doi. 10.1002/ijc.2910600120

By:

Wels, Winfried;
Beerli, Roger;
Hellmann, Peter;
Schmidt, Mathias;
Marte, Barbara M.;
Kornilova, Elena S.;
Hekele, Armin;
Mendelsohn, John;
Groner, Bernd;
Hynes, Nancy E.

Publication type:

Article

Innate-like NKp30+CD8+ T cells armed with TCR/CAR target tumor heterogeneity.

Published in:

OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.1973783

By:

Correia, Margareta P.;
Stojanovic, Ana;
Wels, Winfried S.;
Cerwenka, Adelheid

Publication type:

Article

Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.

Published in:

OncoImmunology, 2016, v. 5, n. 4, p. N.PAG, doi. 10.1080/2162402X.2015.1119354

By:

Genßler, Sabrina;
Burger, Michael C.;
Zhang, Congcong;
Oelsner, Sarah;
Mildenberger, Iris;
Wagner, Marlies;
Steinbach, Joachim P.;
Wels, Winfried S.

Publication type:

Article

Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibodydependent cellular cytotoxicity.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26527-1, doi. 10.4161/onci.26527

By:

Boissel, Laurent;
Betancur-Boissel, Monica;
Weiquan Lu;
Krause, Daniela S.;
Van Etten, Richard A.;
Wels, Winfried S.;
Klingemann, Hans

Publication type:

Article

Arming NK cells with enhanced antitumor activity.

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.25220

By:

Oberoi, Pranav;
Wels, Winfried S.

Publication type:

Article

3D model for CAR‐mediated cytotoxicity using patient‐derived colorectal cancer organoids.

Published in:

EMBO Journal, 2019, v. 38, n. 12, p. 1, doi. 10.15252/embj.2018100928

By:

Schnalzger, Theresa E;
Groot, Marnix HP;
Zhang, Congcong;
Mosa, Mohammed H;
Michels, Birgitta E;
Röder, Jasmin;
Darvishi, Tahmineh;
Wels, Winfried S;
Farin, Henner F

Publication type:

Article

Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo.

Published in:

International Journal of Cancer, 2007, v. 120, n. 2, p. 329, doi. 10.1002/ijc.22168

By:

Novak, Hila;
Noy, Roy;
Oved, Kfir;
Segal, Dina;
Wels, Winfried S.;
Reiter, Yoram

Publication type:

Article

Replacement of N-terminal portions of TGF-α with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.

Published in:

International Journal of Cancer, 2002, v. 97, n. 3, p. 349, doi. 10.1002/ijc.1618

By:

Schmidt, Mathias;
Wels, Winfried

Publication type:

Article

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo.

Published in:

International Journal of Cancer, 2000, v. 86, n. 2, p. 269, doi. 10.1002/(SICI)1097-0215(20000415)86:2<269::AID-IJC18>3.0.CO;2-8

By:

Azemar, Marc;
Schmidt, Mathias;
Arlt, Friederike;
Kennel, Pierre;
Brandt, Burkhard;
Papadimitriou, Apollon;
Groner, Bernd;
Wels, Winfried

Publication type:

Article

In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome.

Published in:

EMBO Molecular Medicine, 2018, v. 10, n. 11, p. N.PAG, doi. 10.15252/emmm.201809158

By:

Pfeiffer, Anett;
Thalheimer, Frederic B;
Hartmann, Sylvia;
Frank, Annika M;
Bender, Ruben R;
Danisch, Simon;
Costa, Caroline;
Wels, Winfried S;
Modlich, Ute;
Stripecke, Renata;
Verhoeyen, Els;
Buchholz, Christian J

Publication type:

Article

Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system.

Published in:

Expert Opinion on Biological Therapy, 2020, v. 20, n. 12, p. 1491, doi. 10.1080/14712598.2020.1803273

By:

Lazarova, Mariya;
Wels, Winfried S.;
Steinle, Alexander

Publication type:

Article

Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2905, doi. 10.1007/s00262-023-03374-x

By:

Pfeifer Serrahima, Jordi;
Zhang, Congcong;
Oberoi, Pranav;
Bodden, Malena;
Röder, Jasmin;
Arndt, Claudia;
Feldmann, Anja;
Kiefer, Anne;
Prüfer, Maren;
Kühnel, Ines;
Tonn, Torsten;
Bachmann, Michael;
Wels, Winfried S.

Publication type:

Article

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 4, p. 513, doi. 10.1007/s00262-018-2119-y

By:

Krackhardt, Angela M.;
Anliker, Brigitte;
Hildebrandt, Martin;
Bachmann, Michael;
Eichmüller, Stefan B.;
Nettelbeck, Dirk M.;
Renner, Matthias;
Uharek, Lutz;
Willimsky, Gerald;
Schmitt, Michael;
Wels, Winfried S.;
Schüssler-Lenz, Martina

Publication type:

Article

Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 25, doi. 10.1007/s00262-017-2055-2

By:

Nowakowska, Paulina;
Romanski, Annette;
Miller, Nicole;
Odendahl, Marcus;
Bonig, Halvard;
Zhang, Congcong;
Seifried, Erhard;
Wels, Winfried S.;
Tonn, Torsten

Publication type:

Article

NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 485, doi. 10.1007/s00262-015-1761-x

By:

Suck, Garnet;
Odendahl, Marcus;
Nowakowska, Paulina;
Seidl, Christian;
Wels, Winfried;
Klingemann, Hans;
Tonn, Torsten

Publication type:

Article

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 621, doi. 10.1007/s00262-015-1669-5

By:

Seidel, Diana;
Shibina, Anastasia;
Siebert, Nikolai;
Wels, Winfried;
Reynolds, C.;
Huebener, Nicole;
Lode, Holger

Publication type:

Article

Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 9, p. 1451, doi. 10.1007/s00262-012-1212-x

By:

Sahm, Christiane;
Schönfeld, Kurt;
Wels, Winfried

Publication type:

Article

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 9, p. 1473, doi. 10.1007/s00262-012-1215-7

By:

Burkhardt, Ute;
Sloots, Arjen;
Jakobi, Vera;
Wei, Wei-Zen;
Cavallo, Federica;
Kloke, Björn-Philipp;
Wels, Winfried

Publication type:

Article

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 411, doi. 10.1007/s00262-007-0383-3

By:

Müller, Tina;
Uherek, Christoph;
Maki, Guitta;
Kai UweChow;
Schimpf, Annemarie;
Klingemann, Hans-Georg;
Tonn, Torsten;
Wels, Winfried S.

Publication type:

Article

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 217, doi. 10.1007/s00262-003-0482-8

By:

Wels, Winfried;
Biburger, Markus;
Müller, Tina;
Dälken, Benjamin;
Giesübel, Ulrike;
Tonn, Torsten;
Uherek, Christoph

Publication type:

Article

Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor.

Published in:

Molecular Therapy, 2015, v. 23, n. 2, p. 330, doi. 10.1038/mt.2014.219

By:

Schönfeld, Kurt;
Sahm, Christiane;
Zhang, Congcong;
Brendel, Christian;
Köhler, Sylvia;
Grez, Manuel;
Rieger, Michael A;
Wels, Winfried S;
Naundorf, Sonja;
Kühlcke, Klaus;
Odendahl, Marcus;
Tonn, Torsten;
Nowakowska, Paulina;
Bönig, Halvard;
Seifried, Erhard;
Köhl, Ulrike;
Kloess, Stephan;
Holtgreve-Grez, Heidi;
Jauch, Anna;
Schmidt, Manfred

Publication type:

Article

Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression.

Published in:

Molecular Therapy, 2009, v. 17, n. 10, p. 1779, doi. 10.1038/mt.2009.133

By:

Ahmed, Nabil;
Salsman, Vita S.;
Yvon, Eric;
Louis, Chrystal U.;
Perlaky, Laszlo;
Wels, Winfried S.;
Dishop, Meghan K.;
Kleinerman, Eugenie E.;
Pule, Martin;
Rooney, Cliona M.;
Heslop, Helen E.;
Gottschalk, Stephen

Publication type:

Article

766. Immunotherapy for Her2-Positive Medulloblastoma: Regression of Experimental Tumors by Transfer of Her2-Redirected T Cells In Vivo.

Published in:

Molecular Therapy, 2006, v. 13, p. S296, doi. 10.1016/j.ymthe.2006.08.851

By:

Ahmed, Nabil M.;
Ratnayake, Maheshika K.;
Savoldo, Barbara;
Perlaky, Laszlo;
Dotti, Gianpietro;
Wels, Winfried;
Bhattacharjee, Meenakshi B.;
Shine, H. David;
Rooney, Cliona M.;
Heslop, Helen E.;
Gottschalk, Stephen

Publication type:

Article

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1485817

By:

Moser, Laura M.;
Heim, Catrin;
Koschade, Sebastian E.;
Wendel, Philipp;
Bozkurt, Süleyman;
Harenkamp, Sabine;
Kreyenberg, Hermann;
Merker, Michael;
Münch, Christian;
Gradhand, Elise;
Vogler, Meike;
Ullrich, Evelyn;
Bönig, Halvard;
Klusmann, Jan-Henning;
Bader, Peter;
Wels, Winfried S.;
Rettinger, Eva

Publication type:

Article

Bispecific killer cell engagers employing species crossreactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2- positive malignancies.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1457887

By:

Serrahima, Jordi Pfeifer;
Schoenfeld, Katrin;
Kühnel, Ines;
Harwardt, Julia;
Palacios, Arturo Macarrón;
Prüfer, Maren;
Kolaric, Margareta;
Oberoi, Pranav;
Kolmar, Harald;
Wels, Winfried S.

Publication type:

Article

Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth.

Published in:

International Journal of Cancer, 2019, v. 145, n. 7, p. 1935, doi. 10.1002/ijc.32269

By:

Oelsner, Sarah;
Waldmann, Anja;
Billmeier, Arne;
Röder, Jasmin;
Lindner, Aline;
Ullrich, Evelyn;
Marschalek, Rolf;
Dotti, Gianpietro;
Jung, Gundram;
Große‐Hovest, Ludger;
Oberoi, Pranav;
Bader, Peter;
Wels, Winfried S.

Publication type:

Article

Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.

Published in:

International Journal of Cancer, 2016, v. 139, n. 8, p. 1799, doi. 10.1002/ijc.30217

By:

Oelsner, Sarah;
Wagner, Juliane;
Friede, Miriam E.;
Pfirrmann, Verena;
Genßler, Sabrina;
Rettinger, Eva;
Buchholz, Christian J.;
Pfeifer, Heike;
Schubert, Ralf;
Ottmann, Oliver G.;
Ullrich, Evelyn;
Bader, Peter;
Wels, Winfried S.

Publication type:

Article

A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.

Published in:

International Journal of Cancer, 2014, v. 134, n. 11, p. 2547, doi. 10.1002/ijc.28585

By:

Müller, Nina;
Hartmann, Cord;
Genßler, Sabrina;
Koch, Joachim;
Kinner, Andrea;
Grez, Manuel;
Wels, Winfried S.

Publication type:

Article

Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).

Published in:

2018

By:

Deola, Sara;
Guerrouahen, Bella S.;
Sidahmed, Heba;
Al-Mohannadi, Anjud;
Elnaggar, Muhammad;
Elsadig, Ramaz;
Abdelalim, Essam M.;
Petrovski, Goran;
Gadina, Massimo;
Thrasher, Adrian;
Wels, Winfried S.;
Hunger, Stephen P.;
Wang, Ena;
Marincola, Francesco M.;
Maccalli, Cristina;
Cugno, Chiara;
ATH Consortium

Publication type:

research